Abstract |
This study evaluates the effectiveness of immunomodulating drug isoprinosine in a comprehensive treatment of genital warts in men. Most of the patients were aged 20-30 years. The combination therapy was found to have long term effectiveness. In the group of patients undergoing only destructive methods of treatment relapse after 8 month follow-up was diagnosed in 32% and in patients of the combination therapy group (destruction plus isoprinosine) - in 7% of patients. The pharmacological action of the drug (immunostimulating, antiviral) and the effectiveness of its combination with destructive therapies justify the use of inosine pranobex ( isoprinosine) both in the complex therapy of genital warts and for the prevention of the disease recurrence.
|
Authors | B A Nejmark, Ju S Kondrat'eva, V S Zologina, D V Torbik |
Journal | Urologiia (Moscow, Russia : 1999)
(Urologiia)
2015 Mar-Apr
Issue 2
Pg. 39-40, 42
ISSN: 1728-2985 [Print] Russia (Federation) |
PMID | 26237804
(Publication Type: Clinical Trial, English Abstract, Journal Article)
|
Chemical References |
- Adjuvants, Immunologic
- Antiviral Agents
- Inosine Pranobex
|
Topics |
- Adjuvants, Immunologic
(administration & dosage, adverse effects, therapeutic use)
- Adult
- Antiviral Agents
(administration & dosage, adverse effects, therapeutic use)
- Combined Modality Therapy
- Condylomata Acuminata
(drug therapy, immunology, surgery, virology)
- Drug Therapy, Combination
- Genital Diseases, Male
(drug therapy, immunology, surgery, virology)
- Humans
- Inosine Pranobex
(administration & dosage, adverse effects, therapeutic use)
- Male
- Papillomavirus Infections
(drug therapy, immunology, surgery, virology)
- Treatment Outcome
- Young Adult
|